BioMark Diagnostics's total assets for Q2 2024 were C$877.84K, a decrease of -12.76% from the previous quarter. TSE:BUX total liabilities were C$1.91M for the fiscal quarter, a 15.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.